Multifunctional biomaterial platforms for blocking the fibrosis process and promoting cellular restoring effects in myocardial fibrosis therapy
Myocardial fibrosis is the result of abnormal healing after acute and chronic myocardial damage and is a direct cause of heart failure and cardiac insufficiency. The clinical approach is to preserve cardiac function and inhibit fibrosis through surgery aimed at dredging blood vessels. However, this...
Main Authors: | Tian Yue, Shiqiang Xiong, Dezhi Zheng, Yi Wang, Pan Long, Jiali Yang, Dunzhu Danzeng, Han Gao, Xudong Wen, Xin Li, Jun Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.988683/full |
Similar Items
-
Injectable hydrogel-based combination therapy for myocardial infarction: a systematic review and Meta-analysis of preclinical trials
by: Han Gao, et al.
Published: (2024-02-01) -
The Potential Role of Ionic Liquid as a Multifunctional Dental Biomaterial
by: Md Iqbal Hossain, et al.
Published: (2023-11-01) -
Allogeneic biomaterial: a fibrosis inhibitor in ischemic myocardial damage
by: A. I. Lebedeva, et al.
Published: (2023-04-01) -
Engineering multifunctional bioactive citrate-based biomaterials for tissue engineering
by: Min Wang, et al.
Published: (2023-01-01) -
Effect of exogenous adiponectin on myocardial fibrosis in mice models with myocardial fibrosis
by: Feng-Lin Jin, et al.
Published: (2016-01-01)